To Study the Incidence of Uterine Fibroid in Gynaecological Patients
Creators
- 1. Senior Resident, Dept. of OBGY, Sri Aurobindo Institute of Medical Sciences, Indore, M.P.
Description
Background & Methods: The aim of the study is to study incidence of uterine fibroid in gynaecological patients. Most of the studies of fibroid have been based on care-seeking populations, including women undergoing myomectomy or hysterectomy. Among those tumors that come to clinical attention, only a portion of affected women progress to hysterectomy. The decision for surgical intervention primarily reflects the severity of a woman’s symptoms (bleeding or pelvic pain) and her desire to maintain childbearing potential. Results: Total 7% of cases had associated ovarian cyst. The chi-square statistic is 8.1593. The p-value is 0.016914. The result is significant at p < 0.05. Maximum (88%) had less than 2 fibroids. The chi-square statistic is 1.0297. The p-value is 0.031218. The result is significant at p < 0.05. Conclusion: Epidemiologic studies on age at menarche in relation to uterine fibroid have shown an inverse association. The mean age was 12.4±1.29 and the median age was 12 years. On the basis of our current state of knowledge, we can only speculate upon the initiators of this common condition. Future research efforts may provide a better understanding, however, of the causes and mechanisms of uterine fibroid tumorigenesis. Insights resulting from elucidation of the basic biology of these tumors might then be successfully translated into preventative strategies that will reduce the incidence and/or morbidity of this disease.
Abstract (English)
Background & Methods: The aim of the study is to study incidence of uterine fibroid in gynaecological patients. Most of the studies of fibroid have been based on care-seeking populations, including women undergoing myomectomy or hysterectomy. Among those tumors that come to clinical attention, only a portion of affected women progress to hysterectomy. The decision for surgical intervention primarily reflects the severity of a woman’s symptoms (bleeding or pelvic pain) and her desire to maintain childbearing potential. Results: Total 7% of cases had associated ovarian cyst. The chi-square statistic is 8.1593. The p-value is 0.016914. The result is significant at p < 0.05. Maximum (88%) had less than 2 fibroids. The chi-square statistic is 1.0297. The p-value is 0.031218. The result is significant at p < 0.05. Conclusion: Epidemiologic studies on age at menarche in relation to uterine fibroid have shown an inverse association. The mean age was 12.4±1.29 and the median age was 12 years. On the basis of our current state of knowledge, we can only speculate upon the initiators of this common condition. Future research efforts may provide a better understanding, however, of the causes and mechanisms of uterine fibroid tumorigenesis. Insights resulting from elucidation of the basic biology of these tumors might then be successfully translated into preventative strategies that will reduce the incidence and/or morbidity of this disease.
Files
IJPCR,Vol16,Issue6,Article28.pdf
Files
(260.3 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:a982a6a4f00d54bd847d617d3747e772
|
260.3 kB | Preview Download |
Additional details
Dates
- Accepted
-
2024-06-10
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/16/IJPCR,Vol16,Issue6,Article28.pdf
- Development Status
- Active
References
- 1. Stewart EA, et al. The burden of uterine fibroids for African-American women: results of a national survey. J Womens Health (Larchmt) . 2013; 22(10):807–816. 2. Baird DD. Hypothesis: vitamin D protects against uterine fibroid development [Abstract]. Ann Epidemiol. 2008; 18(9):710. 3. Luisi S, et al. Low serum concentrations of di- (2-ethylhexyl) phthalate in women with uterine fibromatosis. Gynecol Endocrinol. 2006;22(2) :92–95. 4. Becker ER. National trends and determinants of hospitalization costs and lengths-of-stay for uterine fibroids procedures. Journal of Health Care Finance. 2007; 33(3):1–16. 5. Becker ER, et al. Inpatient surgical treatment patterns for patients with uterine fibroids in the United States, 1998–2002. J Natl Med Assoc. 2005; 97(10):1336–1342. 6. Viswanathan M, et al. Management of uterine fibroids: an update of the evidence. Evid Rep Technol Assess (Full Rep). 2007; 154:1–122. 7. Kjerulff KH, et al. Uterine leiomyomas: racial differences in severity, symptoms, and age at diagnosis. J Reprod Med. 1996; 41(7):483– 490. 8. Lippman SA, et al. Uterine fibroids and gynecologic pain symptoms in a population-based study. Fertil Steril. 2003; 80(6):1488–1494. 9. Ross RK, et al. Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. Br Med J Clin Res Ed. 1986;293 (6543):359–362. 10. Asada H, et al. Potential link between estrogen receptor-alpha gene hypomethylation and uterine fibroid formation. Mol Hum Reprod. 2008; 14(9):539–545. 11. Okolo S. Incidence, aetiology and epidemiology of uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2008; 22(4):571–588. 12. Moravek MB, Bulun SE. Endocrinology of uterine fibroids: steroid hormones, stem cells, and genetic contribution. Curr Opin Obstet Gynecol. 2015; 27(4):276–283.